5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells

[1]  W. Cao,et al.  Rapid stabilisation of atherosclerotic plaque with 5-aminolevulinic acid-mediated sonodynamic therapy , 2015, Thrombosis and Haemostasis.

[2]  K. Newton.  RIPK1 and RIPK3: critical regulators of inflammation and cell death. , 2015, Trends in cell biology.

[3]  Chandra M Sehgal,et al.  A review of low-intensity ultrasound for cancer therapy. , 2015, Ultrasound in medicine & biology.

[4]  Junying Yuan,et al.  Activation of necroptosis in multiple sclerosis. , 2015, Cell reports.

[5]  W. Kaiser,et al.  Suppression of RIP3-dependent Necroptosis by Human Cytomegalovirus , 2015, The Journal of Biological Chemistry.

[6]  Nikolitsa Nomikou,et al.  Treating cancer with sonodynamic therapy: A review , 2015, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[7]  T. Vanden Berghe,et al.  Necroptosis, in vivo detection in experimental disease models. , 2014, Seminars in cell & developmental biology.

[8]  Xiujin Li,et al.  Expression of the RIP-1 Gene and its Role in Growth and Invasion of Human Gallbladder Carcinoma , 2014, Cellular Physiology and Biochemistry.

[9]  M. Pasparakis,et al.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis , 2014, Nature.

[10]  T. Nishikata,et al.  Case report: A breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy. , 2014, Anticancer research.

[11]  Hongyan Dong,et al.  PEDF and PEDF-derived peptide 44mer protect cardiomyocytes against hypoxia-induced apoptosis and necroptosis via anti-oxidative effect , 2014, Scientific Reports.

[12]  H. Sawai.  Characterization of TNF-induced caspase-independent necroptosis. , 2014, Leukemia research.

[13]  W. Cao,et al.  The Predominant Pathway of Apoptosis in THP-1 Macrophage-Derived Foam Cells Induced by 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy is the Mitochondria-Caspase Pathway Despite the Participation of Endoplasmic Reticulum Stress , 2014, Cellular Physiology and Biochemistry.

[14]  J. Bertin,et al.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition , 2014, Proceedings of the National Academy of Sciences.

[15]  W. Liu,et al.  1,2-benzisothiazol-3-one derivatives as a novel class of small-molecule caspase-3 inhibitors. , 2014, Bioorganic & Medicinal Chemistry.

[16]  Matthew R Trendowski.  The promise of sonodynamic therapy , 2014, Cancer and Metastasis Reviews.

[17]  C. Walsh.  Grand challenges in cell death and survival: apoptosis vs. necroptosis , 2014, Front. Cell Dev. Biol..

[18]  S. Anker,et al.  Mitochondrial cytopathies and cardiovascular disease , 2014, Heart.

[19]  W. Cao,et al.  Apoptosis of THP-1 macrophages induced by protoporphyrin IX-mediated sonodynamic therapy , 2013, International journal of nanomedicine.

[20]  H. Sawai.  Differential effects of caspase inhibitors on TNF-induced necroptosis. , 2013, Biochemical and biophysical research communications.

[21]  Qiao Wu,et al.  A role of RIP3-mediated macrophage necrosis in atherosclerosis development. , 2013, Cell reports.

[22]  Kenta Moriwaki,et al.  The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis , 2012, Cell.

[23]  R. Knight,et al.  Necroptosis , 2012, JAK-STAT.

[24]  Ji Luo,et al.  Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis , 2012, Proceedings of the National Academy of Sciences.

[25]  Xiaodong Wang,et al.  Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.

[26]  Chuan-Qi Zhong,et al.  Programmed necrosis: backup to and competitor with apoptosis in the immune system , 2011, Nature Immunology.

[27]  R. Xavier,et al.  CASPASE 8 inhibits programmed necrosis by processing CYLD , 2011, Nature Cell Biology.

[28]  R. Hakem,et al.  RIP3 mediates the embryonic lethality of caspase-8-deficient mice , 2011, Nature.

[29]  C. Bao,et al.  Interferon-α priming promotes lipid uptake and macrophage-derived foam cell formation: a novel link between interferon-α and atherosclerosis in lupus. , 2011, Arthritis and rheumatism.

[30]  L. Martin,et al.  Necrostatin Decreases Oxidative Damage, Inflammation, and Injury after Neonatal HI , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  Joan W. Miller,et al.  Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis , 2010, Proceedings of the National Academy of Sciences.

[32]  P. Vandenabeele,et al.  Molecular mechanisms of necroptosis: an ordered cellular explosion , 2010, Nature Reviews Molecular Cell Biology.

[33]  B. Schäfer,et al.  Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. , 2010, The Journal of clinical investigation.

[34]  R. Moss,et al.  Sonodynamic and Photodynamic Therapy in Advanced Breast Carcinoma: A Report of 3 Cases , 2009, Integrative cancer therapies.

[35]  F. Chan,et al.  Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation , 2009, Cell.

[36]  L. Galluzzi,et al.  Necroptosis: A Specialized Pathway of Programmed Necrosis , 2008, Cell.

[37]  M. Moskowitz,et al.  Necrostatin-1 Reduces Histopathology and Improves Functional Outcome after Controlled Cortical Impact in Mice , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  Yide Mei,et al.  Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. , 2007, Cellular signalling.

[39]  P. Vandenabeele,et al.  RIP1, a kinase on the crossroads of a cell's decision to live or die , 2007, Cell Death and Differentiation.

[40]  L. Meijer,et al.  7-Bromoindirubin-3′-oxime induces caspase-independent cell death , 2006, Oncogene.

[41]  J. Borén,et al.  ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo. , 2006, Atherosclerosis.

[42]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 , 2005, Cell Death and Differentiation.

[43]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[44]  M. Manns,et al.  Caspase 8 small interfering RNA prevents acute liver failure in mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Winoto,et al.  FADD Is Required for DR4- and DR5-mediated Apoptosis , 2000, The Journal of Biological Chemistry.

[46]  Koshiro Umemura,et al.  Hematoporphyrin as a Sensitizer of Cell‐damaging Effect of Ultrasound , 1989, Japanese journal of cancer research : Gann.

[47]  Junying Yuan,et al.  SnapShot: Necroptosis , 2014, Cell.

[48]  O. Heck,et al.  Report of 3 cases , 2014 .

[49]  I. Tabas.  Macrophage death and defective inflammation resolution in atherosclerosis , 2010, Nature Reviews Immunology.

[50]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death , 2005, Cell Death and Differentiation.

[51]  A. Winoto,et al.  FADD Is Required for DR 4-and DR 5-mediated Apoptosis LACK OF TRAIL-INDUCED APOPTOSIS IN FADD-DEFICIENT MOUSE EMBRYONIC FIBROBLASTS , 2000 .

[52]  Robert C. Wolpert,et al.  A Review of the , 1985 .